NCT04973007 2026-04-22
Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases
University of Colorado, Denver
Phase 4 Terminated
Clinical Trials
13 trialsNCT04288323 2026-02-12
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
University of California, San Diego
Phase 4 Completed
NCT04373564 2026-01-22
ODYSSEY
Guerbet
Phase 4 Recruiting
NCT02156739 2025-12-22
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT03215355 2021-01-27
Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium
Nova Scotia Health Authority
Phase 4 Withdrawn
NCT01490203 2018-03-23
LiFE
Seoul National University Hospital
Completed
NCT02226666 2017-01-13
Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration
University of Michigan
Completed
NCT01043523 2016-11-28
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
Bayer
Completed
NCT01575574 2016-08-23
PRIGA
Fundacion Clinic per a la Recerca Biomédica
Phase 4 Completed
NCT02578602 2015-10-19
MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer
University of Southern California
Phase 1 Completed
NCT01968629 2015-09-23
24hr Imaging Of HCC After EOVIST
Massachusetts General Hospital
Phase EARLY_PHASE1 Withdrawn
NCT01764438 2013-01-09
PrimovistMRI
Inha University Hospital
Unknown
NCT01341132 2011-04-25
Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents
San Francisco Veterans Affairs Medical Center
Unknown